These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 12003383)

  • 1. Telomerase activity in pancreatic endocrine tumors.
    Tang SJ; Dumot JA; Wang L; Memmesheimer C; Conwell DL; Zuccaro G; Goormastic M; Ormsby AH; Cowell J
    Am J Gastroenterol; 2002 Apr; 97(4):1022-30. PubMed ID: 12003383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
    Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
    Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
    Wisnoski NC; Townsend CM; Nealon WH; Freeman JL; Riall TS
    Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: long-term survival analysis.
    Sarmiento JM; Farnell MB; Que FG; Nagorney DM
    World J Surg; 2002 Oct; 26(10):1267-71. PubMed ID: 12205558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
    Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M
    Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
    Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
    J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior.
    Roldo C; Missiaglia E; Hagan JP; Falconi M; Capelli P; Bersani S; Calin GA; Volinia S; Liu CG; Scarpa A; Croce CM
    J Clin Oncol; 2006 Oct; 24(29):4677-84. PubMed ID: 16966691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acinar cell carcinoma of the pancreas: is the absence of neuroendocrine component related to a more malignant behavior?
    Machado MC; Machado MA; Perini MV; Herman P; Jukemura J; Leite KR; Bacchella T
    Hepatogastroenterology; 2008; 55(82-83):708-10. PubMed ID: 18613439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic acinar cell carcinoma with endocrine differentiation: immunohistochemical and ultrastructural analyses.
    Tobita K; Kijima H; Chino O; Dowaki S; Kashiwagi H; Tanaka M; Ohtani Y; Inokuchi S; Makuuchi H
    Anticancer Res; 2001; 21(3C):2131-4. PubMed ID: 11501836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study.
    Gullo L; Migliori M; Falconi M; Pederzoli P; Bettini R; Casadei R; Delle Fave G; Corleto VD; Ceccarelli C; Santini D; Tomassetti P
    Am J Gastroenterol; 2003 Nov; 98(11):2435-9. PubMed ID: 14638345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acinar cell carcinoma of the pancreas: clinical analysis of 115 patients from Pancreatic Cancer Registry of Japan Pancreas Society.
    Kitagami H; Kondo S; Hirano S; Kawakami H; Egawa S; Tanaka M
    Pancreas; 2007 Jul; 35(1):42-6. PubMed ID: 17575544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
    Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
    Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytologic diagnosis of pancreatic endocrine tumors by endoscopic ultrasound-guided fine-needle aspiration: a review.
    Chang F; Chandra A; Culora G; Mahadeva U; Meenan J; Herbert A
    Diagn Cytopathol; 2006 Sep; 34(9):649-58. PubMed ID: 16900463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival.
    Quiros RM; Rao G; Plate J; Harris JE; Brunn GJ; Platt JL; Gattuso P; Prinz RA; Xu X
    Cancer; 2006 Feb; 106(3):532-40. PubMed ID: 16388520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours.
    La Rosa S; Rigoli E; Uccella S; Novario R; Capella C
    Histopathology; 2007 Apr; 50(5):597-606. PubMed ID: 17394496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.
    Panzuto F; Nasoni S; Falconi M; Corleto VD; Capurso G; Cassetta S; Di Fonzo M; Tornatore V; Milione M; Angeletti S; Cattaruzza MS; Ziparo V; Bordi C; Pederzoli P; Delle Fave G
    Endocr Relat Cancer; 2005 Dec; 12(4):1083-92. PubMed ID: 16322345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity in stage II colorectal carcinoma.
    Kawanishi-Tabata R; Lopez F; Fratantonio S; Kim N; Goldblum J; Tubbs R; Elson P; Lavery I; Bukowski RM; Ganapathi R; Ganapathi MK
    Cancer; 2002 Nov; 95(9):1834-9. PubMed ID: 12404275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.